Parecoxib Sodium

Parecoxib Sodium

Parecoxib is a selective COX-2 inhibitor and NSAID used for the short-term management of perioperative pain.Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.

Systematic Name

N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonyl]propanamide

Brand Name(S)

Dynastat

Therapeutic Category

Analgesics

Suitable Formulations

Solid

Approvals

TGA DMF, EU ASMF, CADIFA, TDMF

EU-WC

Do You Have A Question? Lets Have A Talk

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.